Has Vinod Doreswamy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $271 in general payments to Vinod Doreswamy, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Vinod Doreswamy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Vinod Doreswamy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Vinod Doreswamy, MD

Allergy & Immunology · Seattle, WANPI 1689696577

Payments from drug & device makers

$271in general payments, 2019–2025

Across 4 payments — averaging $67.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biocryst US Sales Co., LLC$140
AstraZeneca$102
Pfizer$30

What the payments were for

Food & beverage$271100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biocryst US Sales Co., LLC	2	$140
AstraZeneca	1	$102
Pfizer	1	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

FASENRA$102

How this compares

$271 in reported general payments places this provider in the 20th percentile of 81 allergy & immunology providers in Washington.

See all allergy & immunology providers in Washington →

Medicare billing

Part B allowed, 2024

$1,585,973

Medicare patients

250

Services billed

123,438

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent SyringeDupilumab	27	$104,471
Dupixent PenDupilumab	13	$48,350
XolairOmalizumab	13	$41,761
Breo ElliptaFluticasone/Vilanterol	46	$29,149
Spiriva RespimatTiotropium Bromide	11	$11,865
Incruse ElliptaUmeclidinium Bromide	12	$8,954
Arnuity ElliptaFluticasone Furoate	15	$6,342
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	33	$6,087
Cromolyn Sodium	13	$2,523
Albuterol Sulfate HfaAlbuterol Sulfate	49	$2,490
Fluticasone Propionate	40	$1,326
Azelastine Hcl	36	$1,312
Wixela InhubFluticasone Propion/Salmeterol	12	$1,109
Ipratropium Bromide	34	$1,084
Montelukast Sodium	66	$1,039

Paid to pharmacies, not to this prescriber.

Other allergy & immunology in Seattle

Daniel PetroniSeattle$2M
William HendersonSeattle$296K
Mary FarringtonSeattle$176K
Frank VirantSeattle$107K
Leonard AltmanSeattle$81K
Stephen TillesSeattle$59K
Rahool DaveSeattle$47K
Matthew AltmanSeattle$37K
Gabriel MendozaSeattle$16K
Kelly ColasSeattle$14K

See the full list for Washington →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →